Skip to main content
  1. Home
  2. Emerging Tech
  3. Legacy Archives

Sasse Departs iriver America CEO Position

Add as a preferred source on Google

Digital Trends has learned that a management shake up has occurred at MP3 player manufacturer iriver America. This shake up has resulted in the departure of former CEO Jonathan Sasse for greener pastures.

Sasse, in an email exchange with Digital Trends, confirmed he had in fact left iriver America, makers of the popular clix portable media player, for an undisclosed start up.

Recommended Videos

“An opportunity presented itself late this summer that would allow me to work with another young organization that was just getting started,” said Sasse in an email. “In working with Rio and iriver in the past, this is the part of building companies that I enjoy the most. This came at a time when our Korean parent [Reigncom] was looking to take iriver in a new direction globally, so the timing was right to make a change.”

When asked about the new direction iriver was going and if that had anything to do with the management change, Sasse stated “it was really a combination of things, partly due to our parent company looking to shift some of the global product line focus and partly due to the opportunity that came up. I enjoyed my time at iriver a great deal and should those specific combination of events not occurred I would likely still be there.”

Digital Trends, seeking comment from iriver regarding the management change, was informed by a spokesperson that “Jonathan has left the company to pursue other interests and we will miss him” and “we have made staffing changes in our North American offices that include staffing the offices with several members of the iriver Global team including Andrew Yang, who will be stepping into the role of CEO at iriver America.”

This spokesperson also explained the new direction of iriver America would be “focusing effort on the clix portable media player”.

Sasse, for his part, did not seem upset over the change.

“Clearly I wish iriver all the best,” he said, “as the parent company aligns the roadmap for continued success I would envision some expansion of the device line-up to take advantage of new connected trends in the industry.”

We hope to have more information on iriver’s new CEO Andrew Yang as well as more details on Sasse’s departure shortly.

DT Staff
Digital Trends has a simple mission: to help readers easily understand how tech affects the way they live. We are your…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more